Notice type: 3rd Party Publications
This update is to inform healthcare professionals of a recent update to the product information for Hypovase 0.5 mg tablets, (prazosin hydrochloride). This update relates to the deletion all indications of paediatric use of prazosin in the Summary of Product Characteristics and Patient Information Leaflet.
Please see the document linked below for further information.
Authorisation Holder:
Pfizer Healthcare Ireland